Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
11.92
+0.82 (7.39%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Mesoblast Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Mesoblast stock have an average target of 18, with a low estimate of 12 and a high estimate of 24. The average target predicts an increase of 51.01% from the current stock price of 11.92.
Analyst Consensus: Buy
* Price targets were last updated on Feb 7, 2025.
Analyst Ratings
The average analyst rating for Mesoblast stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $15 → $24 | Buy | Reiterates | $15 → $24 | +101.34% | Feb 7, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 23, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $11 → $15 | Buy | Maintains | $11 → $15 | +25.84% | Dec 19, 2024 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $12 | Hold → Strong Buy | Upgrades | $12 | +0.67% | Sep 24, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Aug 29, 2024 |
Financial Forecast
Revenue This Year
19.39M
from 5.90M
Increased by 228.57%
Revenue Next Year
88.58M
from 19.39M
Increased by 356.77%
EPS This Year
-0.40
from -0.09
EPS Next Year
-0.22
from -0.40
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 32.3M | 143.2M | 382.2M | ||
| Avg | 19.4M | 88.6M | 328.3M | ||
| Low | 12.7M | 61.4M | 280.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 447.9% | 638.6% | 331.5% | ||
| Avg | 228.6% | 356.8% | 270.6% | ||
| Low | 115.9% | 216.9% | 216.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.07 | -0.05 | 0.14 | |
| Avg | -0.40 | -0.22 | 0.01 | |
| Low | -0.72 | -0.38 | -0.19 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.